Biointron’s Q2 2026 Antibody Industry Trends report aims to explore the events and trends of the biopharmaceutical industry in April, May, and June. This quarter, six novel monoclonal antibody drugs have received first approval.
Biointron’s Q1 2026 Antibody Industry Trends report aims to explore the events and trends of the biopharmaceutical industry in January, February, and March. This quarter, three novel monoclonal antibody drugs have been approved by China.
Biointron’s Q2 2025 antibody industry report aims to explore the events and trends of the biopharmaceutical industry in April, May, and June.
Time: April 28 – 30, 2026
Location: Seoul, South Korea
Time: April 17 – 22, 2026
Location: San Diego, CA
Booth: #4154
Time: April 15 - 19, 2026
Location: Boston, MA
Booth: #1228
AI is transforming antibody discovery, but better models only come from better data. When you are generating and screening sequences at scale, you need characterization results that are fast, comprehensive, and ready to use without hours of cleanup and reformatting.
The antibody therapeutics sector is rapidly evolving, transitioning from traditional hybridoma methods to single B and AI-driven de novo design approaches, significantly compressing discovery timelines and creating novel binding moieties.
When you’re a small biotech with big ambitions, every week counts. For Macomics Limited, that meant finding a way to get high-quality antibodies quick···
The demand for fully human therapeutic antibodies continues to grow, driving the need for more efficient discovery platforms.
Case 1: Tag-Free Vaccine Protein. During the generation of stable cell lines, cells are selected and screened to identify clones that stably express t···
Apply for Biointron's Quarterly Travel Grant. Receive $800 to support early-career antibody researchers in attending scientific conferences, symposia, and workshops.
Submit a quick Biointron testimonial and we’ll send you a $25 Amazon gift card. Simple, fast, and appreciated!
Join Biointron’s Google Review & Reward Program! Share your experience on Biointron google profile and earn a $25 gift card as reward!
Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This month in June, we'll highlight the era of AI-driven antibody discovery.
Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This month in May, we'll highlight the future of VHH technology, chemical conjugation in antibody therapeutics, and emerging trends in antibody characterization.
Spotlight on Antibodies is a podcast from Biointron, where we bring you the latest antibody industry trends. This month in April, we'll highlight ATP-dependent switch antibodies, the throughput-quality gap in antibody discovery, and multiple myeloma antibody treatments.
For an antibody candidate, strong target binding is only part of the path toward a successful therapeutic. A molecule can show high affinity and selectivity yet encounter problems later because of poor stability, low expression, aggregation, non-specific binding, or other unfavorable biophysical properties.
Explore VHH-based biosensors for high-sensitivity detection using nanobodies in electrochemical, SPR, and optical diagnostic platforms.
Biointron’s Antibodies After Hours: BIO 2026 Reception was held at The Lion's Share in San Diego on Tuesday, June 23, 2026. Held on the second day of the BIO International Convention, we had a memorable evening of networking, drinks, and delicious appetizers with members of the biotech and pharma community at one of San Diego’s most distinctive downtown venues!
ScientistとScience Exchangeとのご利用可能です。
